Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Core EBITDA Growth

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 34.3714.6689.44-31.9410.94

What is the latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA ?

The latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA is 34.37 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202534.37
Mar202414.66
Mar202389.44
Mar2022-31.94
Mar202110.94

How is Core EBITDA Growth of ASTRAZENECA PHARMA INDIA Trending?

Years Core EBITDA Growth % Change
Mar2025 34.37
134.45
Mar2024 14.66
-83.61
Mar2023 89.44
Positive
Mar2022 -31.94
Negative
Mar2021 10.94 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare Core EBITDA Growth ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹20,624.3 Cr 0.5% -9.1% 23.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,773.0 Cr -6.8% -7.6% -4.7% Stock Analytics
DIVIS LABORATORIES ₹159,540.0 Cr -6.6% -5.8% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,529.0 Cr 0.9% 5.7% 27.3% Stock Analytics
CIPLA ₹111,299.0 Cr -4.8% -8.1% -3.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,393.0 Cr -2% -8.8% -12.9% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

0.5%

-9.1%

23.1%

SENSEX

-2%

-2.8%

7.4%


You may also like the below Video Courses